Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
RG-6540 by F. Hoffmann-La Roche for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
RG-6540 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According...
RG-6540 by F. Hoffmann-La Roche for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
RG-6540 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Diffuse Large B-Cell Lymphoma. According...
RG-6540 by F. Hoffmann-La Roche for Unspecified B-Cell Lymphomas: Likelihood of Approval
RG-6540 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Unspecified B-Cell Lymphomas. According to...
RG-6540 by F. Hoffmann-La Roche for Follicular Lymphoma: Likelihood of Approval
RG-6540 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Follicular Lymphoma. According to GlobalData,...